Mdxhealth Sa ADR (MDXH) Stock Price, Quote & News

Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that iden...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 866 259 5644

Website: mdxhealth.com

Address:

CAP Business Center, Rue d’Abhooz 31 Zone Industrielle des Hauts-Sarts, Herstal, Belgium

tom1_tom1 Jul. 24 at 4:41 PM

$MDXH

0 · Reply

fantastex Jul. 24 at 3:15 PM

$MDXH bankrupcty?

0 · Reply

BioHuntingTwits Jul. 22 at 3:55 PM

$MDXH Can someone explain the numbers here? The market value of the stock is around 20 million. The company earns 100 million, yet the net is negative, minus 10 million. Still, I would expect the market value to be at least double the current value The effect of the litigation is so strong? Isn’t it all about 10 mil? Maybe the debt here is the the reason? What I am missing

3 · Reply

fantastex Jul. 16 at 2:04 PM

$MDXH fucking Company!!!!

0 · Reply

Tritello Jul. 14 at 4:52 PM

$MDXH The August 13 earnings report can only act as a real catalyst if it brings actual new information: runway, burn, partnerships, clinical data, or updated guidance. A “purely accounting” quarter doesn’t move the needle. In microcap biotech, price reacts to news, not to earnings. After months with zero updates, the catalyst has to be substantial to change the structure of the stock

1 · Reply

fantastex Jul. 14 at 3:24 PM

$MDXH trading like BK

0 · Reply

ElonRMusk Jul. 13 at 8:10 PM

$MDXH higher selling volume than normal. Must be another fund group

0 · Reply

Goodstockday Jul. 13 at 5:07 PM

$MDXH A step backwards today after gaining strength last week. When it hit .43, I started buying again. (Another rocky day for most biotechs . . .)

0 · Reply

ElonRMusk Jul. 13 at 2:53 PM

$MDXH 1 month until earnings. May tell a better story

1 · Reply

fantastex Jul. 13 at 2:31 PM

$MDXH trading like BK. FUCK

0 · Reply

MDxHealth receives noncompliance notification from Nasdaq

Jul 24, 2026, 4:59 PM EDT - 2 days ago

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency

2026-07-02T20:05:15.000Z - 24 days ago

MDxHealth receives noncompliance letter from Nasdsaq

Jul 2, 2026, 4:00 PM EDT - 24 days ago

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Jun 29, 2026, 8:00 AM EDT - 27 days ago

Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial

Jun 1, 2026, 7:00 AM EDT - 7 weeks ago

MDxHealth Slides: Corporate presentation

2026-05-14T15:07:54.000Z - 2 months ago

MDxHealth price target lowered to $5 from $9 at Lake Street

2026-05-14T15:06:10.000Z - 2 months ago

MDxHealth price target lowered to $1.50 from $7 at TD Cowen

2026-05-14T13:41:06.000Z - 2 months ago

MDxHealth downgraded to Market Perform from Outperform at William Blair

2026-05-14T12:14:02.000Z - 2 months ago

MDxHealth price target lowered to $4 from $7 at BTIG

2026-05-14T12:07:35.000Z - 2 months ago

MDxHealth to exit the Resolve mdx business

2026-05-14T12:01:25.000Z - 2 months ago

MDxHealth sees FY26 revenue $110M-$115M, consensus $118.6M

May 13, 2026, 4:30 PM EDT - 2 months ago

MDxHealth Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 2 months ago

MDxHealth Earnings release: Q1 2026

2026-05-13T20:07:34.000Z - 2 months ago

MDxHealth reports Q1 EPS (17c) vs. (19c) last year

May 13, 2026, 4:00 PM EDT - 2 months ago

Mdxhealth Reports Q1-2026 Results

May 4, 2026, 7:00 AM EDT - 2 months ago

MDxHealth Slides: Corporate presentation

Apr 30, 2026, 4:00 PM EDT - 3 months ago

Mdxhealth to Release First Quarter 2026 Financial Results on May 13

2026-03-19T15:40:16.000Z - 4 months ago

MDxHealth management to meet virtually with Willlam Blair

Mar 16, 2026, 4:00 PM EDT - 4 months ago

Mdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026

Mar 9, 2026, 7:00 AM EDT - 4 months ago

MDxHealth Slides: Corporate presentation

Feb 26, 2026, 4:30 PM EST - 5 months ago

MDxHealth Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 5 months ago

MDxHealth Annual report: Q4 2025

Feb 26, 2026, 4:30 PM EST - 5 months ago

MDxHealth Earnings release: Q4 2025

2026-02-26T21:07:29.000Z - 5 months ago

MDxHealth reports Q4 EPS (17c) vs. (14c) last year

Feb 12, 2026, 5:00 PM EST - 5 months ago

Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26

Feb 11, 2026, 7:00 AM EST - 5 months ago

MDxHealth Registration statement: Registration Filing

2026-01-12T13:05:09.000Z - 6 months ago

MDxHealth sees Q4 revenue $30.5M, consensus $26.18M

Jan 12, 2026, 8:00 AM EST - 6 months ago

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences

2026-01-06T13:21:29.000Z - 7 months ago

MDxHealth announces next phase of collab with University of Oxford

Jan 6, 2026, 8:00 AM EST - 7 months ago

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer

2025-12-29T21:40:18.000Z - 7 months ago

MDxHealth files $200M ordinary shares offering

Dec 29, 2025, 7:00 AM EST - 7 months ago

MDxHealth Registration statement: Registration Filing

2025-12-02T18:20:31.000Z - 8 months ago

MDxHealth management to meet virtually with BTIG

2025-11-13T14:00:49.000Z - 9 months ago

MDxHealth price target raised to $9 from $7 at Lake Street

2025-11-13T13:36:01.000Z - 9 months ago

MDxHealth price target raised to $7 from $5 at TD Cowen

2025-11-13T12:20:34.000Z - 9 months ago

MDxHealth price target raised to $7 from $6 at BTIG

2025-11-12T21:32:01.000Z - 9 months ago

MDxHealth sees FY25 revenue $108M-$110M, consensus $94.05M

Nov 12, 2025, 4:30 PM EST - 9 months ago

MDxHealth Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 9 months ago

MDxHealth Earnings release: Q3 2025

Nov 11, 2025, 6:00 PM EST - 9 months ago

MDxHealth Slides: Corporate Presentation

Oct 8, 2025, 2:00 AM EDT - 10 months ago

Angle PLC Announces Strategy Update

Aug 5, 2025, 4:30 PM EDT - 1 year ago

MDxHealth Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

MDxHealth Earnings release: Q2 2025

Aug 5, 2025, 4:01 PM EDT - 1 year ago

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

Jul 3, 2025, 1:00 PM EDT - 1 year ago

Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change

May 14, 2025, 4:30 PM EDT - 1 year ago

MDxHealth Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

MDxHealth Earnings release: Q1 2025

May 14, 2025, 4:00 PM EDT - 1 year ago

MDxHealth Reports Q1-2025 Results

Feb 26, 2025, 4:30 PM EST - 1 year ago

MDxHealth Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MDxHealth Annual report: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MDxHealth Earnings release: Q4 2024

Feb 26, 2025, 4:00 PM EST - 1 year ago

Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results

Jan 13, 2025, 5:00 AM EST - 1 year ago

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance

Dec 4, 2024, 3:00 PM EST - 1 year ago

MDxHealth Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 8:30 AM EST - 1 year ago

MDxHealth to Participate in Piper Sandler Healthcare Conference

Nov 6, 2024, 4:30 PM EST - 1 year ago

MDxHealth Earnings Call Transcript: Q3 2024

Nov 6, 2024, 4:30 PM EST - 1 year ago

MDxHealth Earnings release: Q3 2024

Nov 6, 2024, 4:30 PM EST - 1 year ago

MDxHealth Slides: Q3 2024

Nov 6, 2024, 4:00 PM EST - 1 year ago

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024

Sep 25, 2024, 9:31 PM EDT - 1 year ago

MDxHealth Announces Pricing of Offering of Ordinary Shares

Sep 25, 2024, 4:05 PM EDT - 1 year ago

MDxHealth Announces Launch of Offering of Ordinary Shares

Aug 21, 2024, 4:30 PM EDT - 2 years ago

MDxHealth Earnings Call Transcript: Q2 2024

Aug 21, 2024, 4:30 PM EDT - 2 years ago

MDxHealth Earnings release: Q2 2024

Aug 21, 2024, 4:00 PM EDT - 2 years ago

MDxHealth Reports Q2 and Half Year 2024 Results

Aug 12, 2024, 4:00 PM EDT - 2 years ago

MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21

Jul 8, 2024, 8:00 AM EDT - 2 years ago

MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance

Jul 8, 2024, 8:00 AM EDT - 2 years ago

Mdxhealth Appoints Sanford J. Siegel, M.D.

Jul 3, 2024, 8:00 AM EDT - 2 years ago

MDxHealth Registration statement: Registration Filing

Jun 28, 2024, 8:00 AM EDT - 2 years ago

MDxHealth Registration statement: Registration Filing

May 15, 2024, 4:00 PM EDT - 2 years ago

Mdxhealth to Present at Upcoming Investor Conferences

May 1, 2024, 8:30 AM EDT - 2 years ago

MDxHealth Earnings Call Transcript: Q1 2024

May 1, 2024, 8:30 AM EDT - 2 years ago

MDxHealth Earnings release: Q1 2024

May 1, 2024, 7:45 AM EDT - 2 years ago

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

Mar 12, 2024, 4:00 PM EDT - 2 years ago

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

Mar 6, 2024, 4:30 PM EST - 2 years ago

MDxHealth Earnings Call Transcript: Q4 2023

Mar 6, 2024, 4:30 PM EST - 2 years ago

MDxHealth Annual report: Q4 2023

Mar 6, 2024, 4:30 PM EST - 2 years ago

MDxHealth Earnings release: Q4 2023

Mar 6, 2024, 4:00 PM EST - 2 years ago

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results

Feb 21, 2024, 5:00 PM EST - 2 years ago

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

Feb 16, 2024, 8:45 AM EST - 2 years ago

Mdxhealth Announces Resignation of Board Member

Jan 8, 2024, 4:00 PM EST - 2 years ago

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance

Dec 18, 2023, 1:00 AM EST - 2 years ago

MDxHealth Announces Completion of Transition to Single Listing on Nasdaq

Nov 27, 2023, 1:00 AM EST - 2 years ago

MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq

Nov 14, 2023, 4:00 PM EST - 2 years ago

MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference

Nov 8, 2023, 4:30 PM EST - 2 years ago

MDxHealth Earnings Call Transcript: Q3 2023

Nov 8, 2023, 4:30 PM EST - 2 years ago

MDxHealth Earnings release: Q3 2023

Nov 8, 2023, 4:00 PM EST - 2 years ago

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023

Nov 6, 2023, 1:00 AM EST - 2 years ago

MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation

Oct 25, 2023, 4:00 PM EDT - 2 years ago

MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8

Oct 20, 2023, 4:00 PM EDT - 3 years ago

Mdxhealth's New Share Capital Amount and New Number of Shares

Oct 9, 2023, 4:00 PM EDT - 3 years ago

MDxHealth Reports Preliminary Q3-2023 Revenues

Oct 2, 2023, 4:04 PM EDT - 3 years ago

MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting

Sep 26, 2023, 4:46 PM EDT - 3 years ago

Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer

Aug 23, 2023, 4:30 PM EDT - 3 years ago

MDxHealth Earnings release: Q2 2023

Aug 23, 2023, 4:00 PM EDT - 3 years ago

MDxHealth Reports Q2 and Half Year 2023 Results

Aug 10, 2023, 4:00 PM EDT - 3 years ago

MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23

Aug 9, 2023, 4:00 PM EDT - 3 years ago

Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth's Select mdx for Prostate Cancer Test

Jun 30, 2023, 4:00 PM EDT - 3 years ago

MDxHealth Announces Results of its Extraordinary General Shareholders' Meeting

Jun 5, 2023, 5:30 PM EDT - 3 years ago

MDxHealth Announces its Extraordinary General Shareholders' Meeting

May 25, 2023, 4:30 PM EDT - 3 years ago

MDxHealth Announces Results of its Annual and Extraordinary General Shareholders' Meetings

May 23, 2023, 4:00 PM EDT - 3 years ago

MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference

May 15, 2023, 4:30 PM EDT - 3 years ago

MDxHealth Earnings Call Transcript: Q1 2023

May 15, 2023, 4:30 PM EDT - 3 years ago

MDxHealth Earnings release: Q1 2023

May 15, 2023, 4:00 PM EDT - 3 years ago

MDxHealth Reports Q1-2023 Results

May 1, 2023, 4:00 PM EDT - 3 years ago

MDxHealth to Present First Quarter 2023 Financial Results on May 15

Apr 25, 2023, 4:00 PM EDT - 3 years ago

MDxHealth Announces its Ordinary and Extraordinary General Shareholders' Meetings

tom1_tom1 Jul. 24 at 4:41 PM

$MDXH

0 · Reply

fantastex Jul. 24 at 3:15 PM

$MDXH bankrupcty?

0 · Reply

BioHuntingTwits Jul. 22 at 3:55 PM

3 · Reply

fantastex Jul. 16 at 2:04 PM

$MDXH fucking Company!!!!

0 · Reply

Tritello Jul. 14 at 4:52 PM

1 · Reply

fantastex Jul. 14 at 3:24 PM

$MDXH trading like BK

0 · Reply

ElonRMusk Jul. 13 at 8:10 PM

$MDXH higher selling volume than normal. Must be another fund group

0 · Reply

Goodstockday Jul. 13 at 5:07 PM

$MDXH A step backwards today after gaining strength last week. When it hit .43, I started buying again. (Another rocky day for most biotechs . . .)

0 · Reply

ElonRMusk Jul. 13 at 2:53 PM

$MDXH 1 month until earnings. May tell a better story

1 · Reply

fantastex Jul. 13 at 2:31 PM

$MDXH trading like BK. FUCK

0 · Reply

fantastex Jul. 13 at 1:03 PM

$MDXH $1+ this month would be great

0 · Reply

Goodstockday Jul. 10 at 2:50 PM

$MDXH Nice buying opportunity today, but it is one of quite a few buying opps given the broad downward biotech movement.

0 · Reply

fantastex Jul. 10 at 9:11 AM

$MDXH pump It up. We dont Need AWN

0 · Reply

ElonRMusk Jul. 9 at 4:15 PM

$MDXH looks like AWM was the fund group liquidating, i KNEW it wasnt retail. Fund groups have strict policies they must follow, such as all companies they own must be above $1. Means nothing in the long run, but explains the liquidity

0 · Reply

Sconniebadge Jul. 8 at 9:04 PM

$MDXH probably not the greatest sign that AWM disposed of their 5 million shares?

2 · Reply

fantastex Jul. 8 at 5:28 PM

$MDXH curling up with $AMC Many sleepers

0 · Reply

fantastex Jul. 7 at 11:15 AM

$MDXH this better shall pump it up to 1 dollars for a small 10M offering giving cash for some months

0 · Reply

Goodstockday Jul. 6 at 6:29 PM

$MDXH So far today, there has been encouraging price stability. That provides a foundation to build on.

0 · Reply

fantastex Jul. 6 at 2:11 PM

$MDXH let's go back over 0.50. then 0.77

0 · Reply

fantastex Jul. 2 at 2:36 PM

$MDXH this is not a technical rebounds fellas. Who knows, knows. It just broke up the bearish wedge pattern. 0.79 FIRST PT

0 · Reply

Goodstockday Jul. 2 at 1:35 PM

$MDXH Strong out of the gate this morning. We will see how the day goes.

0 · Reply

fantastex Jul. 2 at 1:34 PM

$MDXH 0.67 next then the Sky

0 · Reply

Market Cap	20.29M
Revenue (ttm)	107.88M
Net Income (ttm)	-33.52M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-31.07%
Debt to Equity Ratio	-4.74

Volume	391,900
Avg Vol	993,350
Day's Range	N/A - N/A
Shares Out	49.50M
Stochastic %K	10%
Beta	1.43
Analysts	Strong Sell
Price Target	$3.25